Graham Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Buy |
16,754
+1,597
| +11% | +$29.9K | ﹤0.01% | 942 |
|
|
2025
Q1 | $273K | Buy |
15,157
+5,071
| +50% | +$91.2K | ﹤0.01% | 998 |
|
|
2024
Q4 | $170K | Buy |
+10,086
| New | +$170K | ﹤0.01% | 1076 |
|
|
2024
Q2 | – | Sell |
-3,662
| Closed | -$54.2K | – | 1288 |
|
|
2024
Q1 | $54.2K | Sell |
3,662
-267
| -7% | -$3.95K | ﹤0.01% | 984 |
|
|
2023
Q4 | $57K | Buy |
3,929
+921
| +31% | +$13.4K | ﹤0.01% | 911 |
|
|
2023
Q3 | $32.5K | Sell |
3,008
-5,163
| -63% | -$55.8K | ﹤0.01% | 957 |
|
|
2023
Q2 | $105K | Buy |
8,171
+7,040
| +622% | +$90.8K | ﹤0.01% | 874 |
|
|
2023
Q1 | $14.9K | Buy |
+1,131
| New | +$14.9K | ﹤0.01% | 1005 |
|
|
2022
Q4 | – | Sell |
-93,529
| Closed | -$1.1M | – | 1291 |
|
|
2022
Q3 | $1.1M | Buy |
93,529
+81,364
| +669% | +$960K | 0.04% | 435 |
|
|
2022
Q2 | $137K | Sell |
12,165
-16,321
| -57% | -$184K | 0.01% | 939 |
|
|
2022
Q1 | $851K | Buy |
28,486
+20,137
| +241% | +$602K | 0.03% | 360 |
|
|
2021
Q4 | $221K | Buy |
+8,349
| New | +$221K | 0.01% | 427 |
|